Sutro Biopharma Reports Third Quarter 2021 Financial Results, Business Highlights, and Anticipated 2021 Milestones
- Wednesday, November 10, 2021, 7:16
- Environment
- Add a comment
SOUTH SAN FRANCISCO, Calif., Nov. 10, 2021 /PRNewswire/ — Sutro Biopharma, Inc. (NASDAQ: STRO), a clinical-stage drug discovery, development and manufacturing company focused on the application of precise protein engineering and rational design to create next-generation cancer and…
About the Author
adminasapcorp has written 41558 stories on this site.